The comparative sero-epidemiology of varicella zoster virus in 11 countries in the European region

Vaccine

Volumn 25, Issue 45, 2007, Pages 7866-7872

  Nardone, A ^a   de Ory, F ^b   Carton, M ^c   Cohen, D ^d   van Damme, P ^e   Davidkin, I ^f   Rota, M C ^g   de Melker, H ^h   Mossong, J ⁱ   Slacikova, M ^j   Tischer, A ^k   Andrews, N ^a   Berbers, G ^h   Gabutti, G ^l   Gay, N ^a   Jones, L ^m   Jokinen, S ^f   Kafatos, G ^a   de Aragón, M V Martínez ⁿ   Schneider, F ⁱ   Smetana, Z ^o   Vargova, B ^j   Vranckx, R ^p   Miller, E ^a   more..

^a PUBLIC HEALTH ENGLAND   (United Kingdom)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c HEALTH PROTECTION SURVEILLANCE CENTRE   (Ireland)

^d TEL AVIV UNIVERSITY   (Israel)

^e UNIVERSITY OF ANTWERP   (Belgium)

^f NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^g ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^h NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

ⁱ LABORATOIRE NATIONAL DE SANTÉ   (Luxembourg)

^j Public Health Authority of the Slovak Republic   (Slovakia)

^k ROBERT KOCH INSTITUTE   (Germany)

^l UNIVERSITY OF FERRARA   (Italy)

^m National Virus Reference Laboratory   (Ireland)

ⁿ CARLOS III INSTITUTE OF HEALTH   (Spain)

^o Central Virology Laboratory   (Israel)

^p SCIENTIFIC INSTITUTE OF PUBLIC HEALTH   (Belgium)

more..

Author keywords

Seroepidemiology; Vaccination; Varicella zoster virus

Indexed keywords

VIRUS ANTIBODY;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BELGIUM; CHICKENPOX; CHILD; EPIDEMIC; EUROPE; FEMALE; FINLAND; GERMANY; HERD IMMUNITY; HUMAN; IRELAND; ISRAEL; ITALY; LUXEMBOURG; MOUSE; NETHERLANDS; NONHUMAN; PRIORITY JOURNAL; SLOVAKIA; SPAIN; STANDARDIZATION; UNITED KINGDOM; VARICELLA ZOSTER VIRUS; VIRUS DETECTION;

ANTIBODIES, VIRAL; ANTIGENS, VIRAL; EUROPE; EUROPEAN CONTINENTAL ANCESTRY GROUP; HERPES ZOSTER; HERPESVIRUS 3, HUMAN; HUMANS; IMMUNIZATION; ITALY; NETHERLANDS; SEROEPIDEMIOLOGIC STUDIES; VACCINATION;

EID: 35348845129     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2007.07.036     Document Type: Article

References (43)

1. Miller E., Marshall R., and Vurdien J. Epidemiology, outcome and control of varicella-zoster infection. Rev Med Microbiol 4 (1993) 222-230
2. Gil A., Oyaguez I., Carrasco P., and Gonzalez A. Epidemiology of primary varicella hospitalisations in Spain. Vaccine 20 (2002) 295-298
3. Enders G., Miller E., Cradock-Watson J., Bolley I., and Ridehalgh M. Consequences of varicella and herpes zoster in pregnancy: prospective study of 1739 cases. Lancet 343 (1994) 1548-1551
4. Gershon A.A., Takahashi M., and Seward J. Varicella vaccine. In: Plotkin S.A., and Orenstein W.A. (Eds). Vaccines. 4th ed. (2004), WB Saunders Co., Philadelphia, PA, USA 783-823
5. Centers for Disease Control and Prevention. Prevention of varicella: recommendations of the advisory committee on immunization practices (ACIP). MMWR Recomm Rep 45 RR-11 (1996) 1-36
6. Pinot de Moira A., and Nardone A. Varicella zoster virus vaccination policies and surveillance strategies in Europe. Euro Surveill 10 (2005) 4-5
7. Seward J.F., Watson B.M., Peterson C.L., Mascola L., Pelosi J.W., Zhang J.X., et al. Varicella disease after introduction of varicella vaccine in the United States, 1995-2000. JAMA 287 (2002) 606-611
8. Nguyen H.Q., Jumaan A.O., and Seward J.F. Decline in mortality due to varicella and implementation of varicella vaccination in the United States. N Engl J Med 352 (2005) 450-458
9. Clements D.A., Zaref J.I., Bland C.L., Walter E.B., and Coplan P.M. Partial uptake of varicella vaccine and the epidemiological effect on varicella disease in 11 day-care centers in North Carolina. Arch Pediatr Adolesc Med 155 (2001) 455-461
10. Halloran M.E., Cochi S.L., Lieu T.A., Wharton M., and Fehrs L. Theoretical epidemiologic and morbidity effcets of routine varicella immunization of prescholl children in the United States. Am J Epidemiol 140 (1994) 81-104
11. Brisson M., Edmunds W.J., Gay N.J., Law B., and De Serres G. Modelling the impact of immunization on the epidemiology of varicella zoster virus. Epidemiol Infect 125 (2000) 651-669
12. Begg N., and Miller E. Role of epidemiology in vaccine policy. Vaccine 8 (1990) 180-189
13. Osborne K., Weinberg J., and Miller E. The European sero-epidemiology network (ESEN). Euro Surveill 2 (1997) 93-96
14. Nardone A., and Miller E. Serological surveillance of rubella in Europe: European sero-epidemiology network (ESEN2). Euro Surveill 9 (2004) 5-7
15. Vyse A.J., Gay N.J., Hesketh L.M., Morgan-Capner P., and Miller E. Seroprevalence of antibody to varicella zoster virus in England and Wales in children and young adults. Epidemiol Infect 132 (2004) 1129-1134
16. Wutzler P., Farber I., Wagenpfeil S., Bisanz H., and Tischer A. Seroprevalence of varicella-zoster virus in the German population. Vaccine 20 (2001) 121-124
17. Cohen D.I., Davidovici B.B., Smetana Z., Balicer R.D., Klement E., Mendelson E., et al. Seroepidemiology of varicella zoster in Israel prior to large-scale use of Varicella vaccines. Infection 34 (2006) 208-213
18. Gabutti G., Penna C., Rossi M., Salmaso S., Rota M.C., Bella A., et al. The sero-epidemiology of varicella in Italy. Epidemiol Infect 126 (2001) 433-440
19. Mossong J., Putz L., and Schneider F. Seroprevalence and force of infection of varicella-zoster virus in Luxembourg. Epidemiol Infect 132 (2004) 1121-1127
20. de Melker H., Berbers G., Hahne S., Rumke H., van den Hof S., de Wit A., et al. The epidemiology of varicella and herpes zoster in The Netherlands: implications for varicella zoster virus vaccination. Vaccine 24 (2006) 3946-3952
21. De Ory F., Echevarria J.M., Kafatos G., Anastassopoulou C., Andrews N., Backhouse J., et al. European sero-epidemiology network: standardisation of assays for varicella zoster virus. J Clin Virol 36 (2006) 111-118
22. Kafatos G., Andrews N., and Nardone A. Model selection methodology for inter-laboratory standardisation of antibody titres. Vaccine 23 (2005) 5023-5027
23. Anderson R.M., and May R.M. Infectious diseases of humans: dynamics and control. 2nd ed. (1991), Oxford University Press, Oxford
24. Diekmann O., and Heesterbeek J.A.P. Mathematical epidemiology of infectious diseases: model building, analysis and interpretation (2001), John Wiley and Sons, Chichester
25. Aebi C., Fischer K., Gorgievski M., Matter L., and Muhlemann K. Age-specific sero-prevalence to varicella-zoster virus: a study in Swiss children and analysis of European data. Vaccine 19 (2001) 3097-3103
26. Thiry N., Beutels P., Shkedy Z., Vranckx R., Vandermeulen C., Wielen M.V., et al. The seroepidemiology of primary varicella-zoster virus infection in Flanders (Belgium). Eur J Pediatr 161 (2002) 588-593
27. Kelly H., Riddell M.A., Gidding H.F., Nolan T., and Gilbert G.L. A random cluster survey and a convenience sample give comparable estimates of immunity to vaccine preventable diseases in children of school age in Victoria, Australia. Vaccine 20 (2002) 3130-3136
28. De Melker H.E., Nagelkerde N.J., and Conyn-van Spaendonck M.A. Non-participation in a population-based seroprevalence study of vaccine-preventable diseases. Epidemiol Infect 124 (2000) 255-262
29. Khoshnood B., Debruyne M., Lancon F., Emery C., Fagnani F., Durand I., et al. Seroprevalence of varicella in the French population. Pediatr Infect Dis J 25 (2006) 41-44
30. Munoz M.P., Dominguez A., and Salleras L. Estimated varicella incidence on the basis of a seroprevalence survey. Epidemiol Infect 127 (2001) 501-507
31. Boelle P.Y., and Hanslik T. Varicella in non-immune persons: incidence, hospitalization and mortality rates. Epidemiol Infect 129 (2002) 599-606
32. Harger J.H., Ernest J.M., Thurnau G.R., Moawad A., Thom E., Landon M.B., et al. Frequency of congenital varicella syndrome in a prospective cohort of 347 pregnant women. Obstet Gynecol 100 (2002) 260-265
33. Brisson M., Edmunds W.J., Law B., Gay N.J., Walld R., Brownell M., et al. Epidemiology of varicella zoster virus infection in Canada and the United Kingdom. Epidemiol Infect 127 (2001) 305-314
34. Gidding H.F., MacIntyre C.R., Burgess M.A., and Gilbert G.L. The seroepidemiology and transmission dynamics of varicella in Australia. Epidemiol Infect 131 (2003) 1085-1089
35. Whitaker H.J., and Farrington C.P. Infections with varying contact rates: application to Varicella. Biometrics 60 (2004) 615-623
36. Edmunds W.J., Gay N.J., Kretzschmar M., Pebody R.G., and Wachmann H. ESEN Project. European Sero-epidemiology Network. The pre-vaccination epidemiology of measles, mumps and rubella in Europe: implications for modelling studies. Epidemiol Infect 125 (2000) 635-650
37. Ciofi degli Atti M.L., Rota M.C., Mandolini D., Bella A., Gabutti G., Crovari P., et al. Assessment of varicella underreporting in Italy. Epidemiol Infect 128 (2002) 479-484
38. Thiry N., Beutels P., Tancredi F., Romano L., Zanetti A., Bonanni P., et al. An economic evaluation of varicella vaccination in Italian adolescents. Vaccine 22 (2004) 3546-3562
39. WHO. Varicella vaccine. WHO position paper. Wkly Epidemiol Rec 1998;73:241-8.
40. White C.J. Clinical trials of varicella vaccine in healthy children. Infect Dis Clin North Am 10 (1996) 595-608
41. WHO. Eliminating measles and rubella and preventing congenital rubella infection: WHO European Region strategic plan 2005-2010. Copenhagen, Denmark: WHO; 2005.
42. Milledge J.T., Cooper C.D., and Woolfenden S. Barriers to immunization: attitudes of general practitioners to varicella, the disease and its vaccine. Paediatr Child Health 39 (2003) 368-371
43. Salmon D.A., Moulton L.H., Omer S.B., DeHart M.P., Stokley S., and Halsey N.A. Factors associated with refusal of childhood vaccines among parents of school-aged children: a case-control study. Arch Pediatr Adolesc Med 159 (2005) 470-476